Search For "biopharma"
Biocon stock falls 2 pc after 28 pc fall in Q1 net profit
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], July 24 (ANI): Shares of Biocon Ltd fell by nearly 2 per cent on Friday morning after the biopharmaceutical major posted 28 per cent fall in its June quarter (Q1 FY21) net profit at Rs 149 crore.
Read More
Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Read More
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 5 years, 8 months ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More
Biocon, DKSH collaborate to commercialise 7 generic formulations in SE Asi
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], June 22 (ANI): Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic
Read More
Gilead in talks with Indian drugmakers to produce remdesivir for treatment
Updated : 5 years, 10 months ago IST
New Delhi [India], May 6 (ANI): US-based biopharmaceutical major Gilead Sciences said on Wednesday it is negotiating long-term voluntary licences with several generic drugmakers in India to produce remdesivir for developing countries.
Read More
Gilead's anti-viral remdesivir gets FDA emergency use authorisation for tr
Updated : 5 years, 10 months ago IST
California [USA], May 2 (ANI): US-based biopharmaceutical major Gilead Sciences said that the US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for investigational anti-viral remdesivir to treat COVID-19.
Read More
True North to invest Rs 536 crore in Biocon Biologics for 2.4 pc stake
Updated : 6 years, 2 months ago IST
Bengaluru (Karnataka) [India], Jan 6 (ANI): Biopharmaceuticals major Biocon said on Monday the board of its subsidiary Biocon Biologics has approved a primary equity investment by True North which will invest Rs 536.25 crore to pick 2.44 per cent minority stake in the biosimilars business.
Read More
Dishman Carbogen shares rise by 9 pc after I-T department conducts search
Updated : 6 years, 2 months ago IST
Ahmedabad (Gujarat) [India], Dec 26 (ANI): The share price of Dishman Carbogen Amcis rose by over 9 per cent on Thursday after officials of the Income Tax Department conducted search at the company's offices and manufacturing sites here.
Read More
Biocon elevates Siddharth Mittal to CEO, Joint MD's position
Updated : 6 years, 3 months ago IST
Bengaluru (Karnataka) [India], Dec 3 (ANI): Biopharmaceuticals major Biocon said on Tuesday that Siddharth Mittal has been elevated to the position of Chief Executive Officer and Joint Managing Director.
Read More
Biocon's Biologics drug products facility gets nod from US FDA
Updated : 6 years, 4 months ago IST
Bengaluru (Karnataka) [India], Nov 5 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday it has received an establishment inspection report from the US Food and Drug Administration (FDA) for its biologics drug product facility here, reaffirming its global scale manufacturing capabilit
Read More
Biocon moves up to rank 6th on Science careers' top 20 global pharma list
Updated : 6 years, 4 months ago IST
Bengaluru (Karnataka) [India], Oct 28 (ANI): Biopharmaceuticals major Biocon Ltd said on Monday it has moved up in top 10 global biotech employers ranking for 2019 and continues to be the only company from Asia to feature on the US-based Science magazine's annual careers top 20 employers' li
Read More
Biocon Biologics expands R&D footprint by acquiring assets of Pfizer Healt
Updated : 6 years, 5 months ago IST
Bengaluru (Karnataka) [India], Sep 24 (ANI): Biopharmaceuticals major Biocon Ltd said on Tuesday that its subsidiary has acquired research and development capital assets from Pfizer Healthcare India Ltd.
Read More